Suppliers / Qingdao BAHEAL Pharmaceutical

Qingdao BAHEAL Pharmaceutical

China Updated 9 July 2026

Qingdao BAHEAL Pharmaceutical is a finished-dose manufacturer based in China. It appears in 3 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 22 March 2024 as NAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
3
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 22 March 2024 NAI US FDA
  • 6 December 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3011922870

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 3 1

Questions about Qingdao BAHEAL Pharmaceutical

Does Qingdao BAHEAL Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Qingdao BAHEAL Pharmaceutical. It does have 3 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Qingdao BAHEAL Pharmaceutical FDA-registered?
One site operated by Qingdao BAHEAL Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Qingdao BAHEAL Pharmaceutical's last inspection go?
The most recent inspection on record closed on 22 March 2024 as NAI (No Action Indicated: nothing objectionable was found). 2 inspections are on file.
Where does Qingdao BAHEAL Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
Which regulators recognise Qingdao BAHEAL Pharmaceutical's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Qingdao BAHEAL Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 22 March 2024.

Comparable suppliers

Astrazeneca Pharmaceutical also in China Changzhou Syntheall Pharmaceutical also in China Changzhou Yinsheng Pharmaceutical also in China Chengdu Shuode Pharmaceutical also in China Chia Tai Tianqing Pharmaceutical Group also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates